Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Tadalafil and Tamsulosin
NCT02239484Phase 1Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Mar 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tadalafil and tamsulosin in erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) (3 arms), sponsored by Hanmi Pharmaceutical. Primary endpoints: Maximum Plasma Concentration at Steady State and Area Under the Curve over the Dosing Interval. Started Mar 2014; status: completed.
02
Drugs
tadalafiltamsulosin
03
Conditions
erectile dysfunction (ED)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02239484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239484.